Ocuphire Pharma Investor Updates

8 Ocuphire Clinical trial NCT#04675151 PHARMA Topline VEGA-1 Phase 2 Results Randomized, Multi-Center, Double-Masked, Placebo- Controlled Study of the Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) + 0.4% Low Dose Pilocarpine (LDP) for the Treatment of Presbyopia

View entire presentation